Substance / Medication

Fosinopril sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.
Mousavi Asma, Shojaei Shayan, Abhari Amir Parsa et al. · Am J Hypertens · 2026
PMID: 40717314Meta-Analysis
The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: A Systematic Literature Review and Data Analysis.
Møller Charlotte Agergaard, Nielsen Steffen Flindt, Mose Frank Holden · Am J Hypertens · 2026
PMID: 40717316Meta-Analysis
Arterial spin labeling MRI in assessing cerebral blood flow changes due to hypertension: a systematic review.
Muthu Sathya Sabina, Sukumar Suresh, Kadavigere Rajagopal et al. · J Hypertens · 2026
PMID: 41002015Meta-AnalysisFull text (PMC)
The intergenerational effects of low parental socio-economic position on cardiometabolic and inflammatory outcomes: A systematic review and meta-analysis.
Rivillas-García Juan Carlos, Courtin Emilie, Winpenny Eleanor et al. · Eur J Clin Invest · 2026
PMID: 41020493Meta-AnalysisFull text (PMC)
Intake of coffee and blood pressure: A Mendelian randomized study.
Zhong Jiwen, Huang Sichao, Dong Shaohong et al. · Nutr Metab Cardiovasc Dis · 2026
PMID: 41087205Meta-Analysis
Angiotensin receptor neprilysin inhibitor for the treatment of hypertension: a systematic review and meta-analysis.
Noe Hsu Myat, Sujarit Alisara Sangviroon, Chongmelaxme Bunchai et al. · Hypertens Res · 2026
PMID: 41145713Meta-Analysis
PATHOGENETIC ADVANCES OF FOSINOPRIL SODIUM WITH HYDROCHLOROTHIAZIDE IN OBESE HYPERTENSIVE PATIENTS.
Ashcheulova T, Gerasimchuk N, Rezunenko Y et al. · Georgian Med News · 2017
PMID: 29099702Other
Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support.
Janci Biljana, Medenica Mirjana, Ivanović Darko et al. · Anal Bioanal Chem · 2005
PMID: 16195875Other
[Protective effect of fosinopril sodium pretreatment combined with ischemic postconditioning on rat heart underwent myocardial ischemia/reperfusion injury].
Zhang Da-wu, Zhang Lei, Liu Jian-gang et al. · Zhonghua Xin Xue Guan Bing Za Zhi · 2010
PMID: 21055289Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fosinopril sodium (substance)
SNOMED CT
108570006
UMLS CUI
C0733440

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

3
Conditions
4
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.